Clozapine is described as the gold standard treatment for schizophrenia but a new cohort study suggests it is associated with an increased risk of infections, particularly in older patients, further solidifying the case for holistic care.
The post Clozapine and infection risk: new evidence from Hong Kong’s 20-year cohort study appeared first on National Elf Service.
